Clinical Trials Browser

Interventional × Riluzole × 90 days × Clear all

NCT03722680 2026-05-20

RILUZOX-01

Phase 2 Suspended

Gastrointestinal

Colorectal Neoplasms

NCT01303341 2026-04-13

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Phase 1 Active not recruiting

Melanoma